What can a biotech entrepreneur and a top scientist come up with on a couple of shared flights? Well...
Just weeks before the pandemic hit the states, Gary Glick and Keith Flaherty had a chance to spend 12 hours together, talking craft and trade on board shared flights as they headed to and from a board meeting together.
It may have been the most fruitful 12 hours of Glick’s productive life. They certainly found plenty to talk about.
Glick, a well known biotech entrepreneur and inflammatory specialist, had bumped up to executive chair at IFM Therapeutics just weeks before, after running through a slate of sizable deals with some major pharma players like Novartis.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
